Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DT.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DT.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XCAORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XCAORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XCAECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XCAECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCANCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XCANCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CP.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CP.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.39ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BQ.1.1.39ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BQ.1.1.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.39NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.39NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
BF.40ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BF.40ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BF.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.40NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.40NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BN.1.3.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
BN.1.3.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BN.1.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.3.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BM.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
BM.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BM.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BM.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.57ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BQ.1.1.57ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BQ.1.1.57ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.57ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.57NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.57NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EF.1.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
EF.1.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
EF.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EF.1.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.29ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BQ.1.29ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used